Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 17 04:00PM ET
96.76
Dollar change
-1.35
Percentage change
-1.38
%
IndexS&P 500 P/E- EPS (ttm)-9.79 Insider Own10.00% Shs Outstand255.29M Perf Week0.51%
Market Cap24.71B Forward P/E22.10 EPS next Y4.38 Insider Trans-0.01% Shs Float229.83M Perf Month2.35%
Income-2495.00M PEG- EPS next Q0.99 Inst Own84.61% Short Float1.44% Perf Quarter16.63%
Sales11.35B P/S2.18 EPS this Y19.70% Inst Trans-0.77% Short Ratio2.17 Perf Half Y21.65%
Book/sh55.97 P/B1.73 EPS next Y9.53% ROA-7.55% Short Interest3.30M Perf Year21.74%
Cash/sh2.89 P/C33.43 EPS next 5Y11.67% ROE-15.57% 52W Range62.11 - 99.91 Perf YTD19.50%
Dividend Est.1.67 (1.73%) P/FCF25.60 EPS past 5Y- ROI-10.36% 52W High-3.15% Beta1.27
Dividend TTM2.42 (2.50%) Quick Ratio1.05 Sales past 5Y31.28% Gross Margin26.99% 52W Low55.79% ATR (14)1.99
Dividend Ex-DateJun 21, 2024 Current Ratio1.68 EPS Y/Y TTM-19.21% Oper. Margin7.41% RSI (14)52.26 Volatility2.11% 2.05%
Employees21500 Debt/Eq0.77 Sales Y/Y TTM-7.27% Profit Margin-21.98% Recom2.38 Target Price99.90
Option/ShortYes / Yes LT Debt/Eq0.69 EPS Q/Q764.02% Payout- Rel Volume0.92 Prev Close98.11
Sales Surprise4.35% EPS Surprise31.66% Sales Q/Q-4.23% EarningsMay 06 AMC Avg Volume1.52M Price96.76
SMA200.65% SMA500.73% SMA20017.81% Trades Volume1,427,556 Change-1.38%
Date Action Analyst Rating Change Price Target Change
Jun-07-24Initiated Oppenheimer Outperform $116
May-21-24Downgrade Morgan Stanley Overweight → Equal-Weight $100
May-08-24Upgrade JP Morgan Neutral → Overweight $75 → $100
Apr-18-24Upgrade Barclays Underweight → Equal Weight
Apr-10-24Upgrade Citigroup Neutral → Buy $81 → $100
Mar-08-24Downgrade Argus Buy → Hold
Mar-01-24Initiated Wolfe Research Underperform
Jan-22-24Upgrade Morgan Stanley Equal-Weight → Overweight $81 → $90
Jan-12-24Upgrade Jefferies Hold → Buy $73 → $112
Nov-28-23Upgrade Argus Hold → Buy
Jul-09-24 04:15PM
Jun-30-24 09:12AM
Jun-28-24 09:50AM
Jun-26-24 04:00AM
Jun-24-24 06:35AM
09:50AM Loading…
Jun-12-24 09:50AM
Jun-05-24 11:30AM
May-30-24 04:15PM
04:15PM
May-29-24 04:15PM
May-27-24 06:00AM
May-21-24 12:30PM
12:22PM
May-15-24 09:00AM
May-14-24 04:01PM
08:59AM Loading…
May-13-24 08:59AM
May-10-24 09:27AM
May-09-24 06:43AM
May-08-24 03:30PM
11:18AM
11:11AM
08:34AM
08:05AM
07:36AM
07:00AM
06:52AM
06:52AM
06:52AM
05:44AM
03:21AM
01:06AM Loading…
01:06AM
May-07-24 11:13PM
04:48PM
12:47PM
12:42PM
10:29AM
07:43AM
07:39AM
May-06-24 06:12PM
06:00PM
05:55PM
05:30PM
04:58PM
04:38PM
04:16PM
04:15PM
May-03-24 08:42AM
May-02-24 09:00AM
May-01-24 04:15PM
12:15PM
09:15AM
Apr-29-24 10:00AM
09:00AM
Apr-16-24 04:15PM
Apr-03-24 01:07PM
12:47AM
12:00AM
Mar-28-24 01:38PM
Mar-25-24 08:00PM
Mar-21-24 06:45AM
Mar-20-24 01:59PM
07:04AM
Mar-19-24 12:21PM
06:59AM
06:52AM
06:45AM
Mar-13-24 07:43PM
Mar-11-24 01:01PM
Mar-04-24 03:00AM
Mar-01-24 04:15PM
Feb-29-24 04:15PM
12:01AM
Feb-28-24 08:06PM
07:00AM
Feb-22-24 10:01AM
05:40AM
Feb-21-24 11:14PM
12:06PM
11:24AM
Feb-20-24 06:00PM
04:52PM
04:39PM
04:15PM
11:21AM
Feb-16-24 12:01PM
Feb-15-24 04:00AM
Feb-14-24 09:15AM
Feb-13-24 06:15PM
Feb-06-24 10:19PM
Feb-05-24 06:15PM
Jan-29-24 06:15PM
Jan-24-24 04:15PM
Jan-19-24 06:55AM
Jan-15-24 01:14AM
Jan-11-24 06:23PM
05:10PM
04:15PM
Dec-26-23 07:48PM
05:02AM
Dec-20-23 11:36AM
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world's finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Herriott SimonPres. Health & BioscienceJul 03 '24Option Exercise0.00627010,759Jul 05 04:10 PM
Strzelecki AngelaPresident, Pharma SolutionsJun 13 '24Option Exercise77.162,588199,69011,127Jun 14 04:56 PM
Strzelecki AngelaPresident, Pharma SolutionsJun 13 '24Sale95.662,588247,5608,539Jun 14 04:56 PM
Teles de Mendonca Ana PaulaPresident, ScentMay 06 '24Option Exercise0.0072601,178May 07 07:06 PM
RICHTER GLENN RCFOMay 03 '24Option Exercise0.004,243021,889May 07 07:06 PM
Teles de Mendonca Ana PaulaPresident, ScentMay 03 '24Option Exercise0.007070707May 07 07:06 PM
Strzelecki AngelaPresident, Pharma SolutionsMay 03 '24Option Exercise0.001,06008,868May 07 07:06 PM
O'Byrne KevinDirectorMay 03 '24Option Exercise0.001,67101,933May 07 07:06 PM
Yildiz BerilCAO, SVP & ControllerMay 03 '24Option Exercise0.0084801,588May 07 07:06 PM
Gold Christina ADirectorMay 03 '24Option Exercise0.001,671010,840May 07 07:03 PM
Herriott SimonPres. Health & BioscienceMay 03 '24Option Exercise0.001,591010,625May 07 07:03 PM
Hu GaoxiangDirectorMay 03 '24Option Exercise0.001,67102,105May 07 07:04 PM
Johnson Jennifer AmyEVP, General CounselMay 03 '24Option Exercise0.002,12107,936May 07 07:04 PM
Finzel RalfEVP, Global Operations OfficerMay 03 '24Option Exercise0.001,32604,770May 07 07:03 PM
DAVIDSON CAROL ANTHONYDirectorMay 03 '24Option Exercise0.001,67101,926May 07 06:56 PM
Ferguson Roger W. Jr.DirectorMay 03 '24Option Exercise0.002,62502,625May 07 06:56 PM
Bruno Barry A.DirectorMay 03 '24Option Exercise0.001,67103,205May 07 06:55 PM
Costa Mark JDirectorMay 03 '24Option Exercise0.001,67102,139May 07 06:55 PM
Borg DeborahEVP, Chief HR and D&I OfficerMay 03 '24Option Exercise0.001,768017,188May 07 06:55 PM
Arora YuvrajPresident, NourishMay 03 '24Option Exercise0.0011,538011,538May 07 06:54 PM
Johnson Jennifer AmyEVP, General CounselApr 05 '24Option Exercise0.0096806,165Apr 09 05:28 PM
Herriott SimonPres. Health & Biosci. & ScentApr 05 '24Option Exercise0.001,59009,496Apr 09 05:26 PM
Strzelecki AngelaPresident, Pharma SolutionsApr 05 '24Option Exercise0.001,14008,162Apr 09 05:25 PM
Herriott SimonPres. Health & Biosci. & ScentApr 01 '24Option Exercise0.001,48908,367Apr 03 04:24 PM
Clyburn FrankChief Executive OfficerMar 01 '24Option Exercise0.001,32402,170Mar 05 07:06 PM
Strzelecki AngelaPresident, Pharma SolutionsJan 03 '24Option Exercise0.001,34107,418Jan 04 04:06 PM
Finzel RalfEVP, Global Operations OfficerDec 01 '23Option Exercise0.005,38705,387Dec 04 04:17 PM
Johnson Jennifer AmyEVP, General CounselNov 01 '23Option Exercise0.001,04105,459Nov 03 04:12 PM
Yildiz BerilCAO, SVP & ControllerOct 03 '23Option Exercise0.001,07701,077Oct 05 04:09 PM
RICHTER GLENN RCFOOct 02 '23Option Exercise0.0011,812023,624Oct 04 04:08 PM
Borg DeborahEVP, Chief HR and D&I OfficerSep 01 '23Option Exercise0.0027,614027,614Sep 06 05:24 PM